Table 1.
Target | Forward Primer | Reverse Primer |
---|---|---|
WNT5a | TCCACCTTCCTCTTCACACTGA | CGTGGCCAGCATCACATC |
LEF1 | CAGTGACGAGCACTTTTCTC | CGTGATGGGATATACAGGCT |
LRP5 | GCTGTACCCGCCGATCCT | GGCGCCATTCCTCGAAT |
FZDR1 | CCAAGAGAGGAGCCGAGA | CGGCACAAAGTTCCCAG |
WNT3a | CCTCAAGGACAAGTACGACA | GGCACCTTGAAGTAGGTGTA |
VEGF | ATGACGAGGGCCTGGAGTGTA | CCTATGTGCTGGCCTTGGGA |
GAPDH | GGTGGTCTCCTCTGACTTCAACA | GTTGCTGTAGCCAAATTCGTTGT |
Wnt5a: wingless type MMTV integration site family, member 5A, Lef1: lymphoid enhancer-binding factor-1, LRP5: low-density lipoprotein receptor-related protein 5, FZDR1: frizzled receptor 1, Wnt3a: wingless type MMTV integration site family, member 3, VEGF: vascular endothelial growth factor, GAPDH: glyceraldehyde 3-phosphate dehydrogenase.